Abstract
Breast cancer (BC) is one of most important mortality factors among women therefore to find important genes in BC can help early diagnosis, treatment or prevention. TNFSF or tumor necrosis factor Superfamily have an important role in various cancers. In BC, some of studies have found dual roles for these genes. In this research, we conducted a comprehensive and detailed bioinformatics study on this family. UALCAN, TNMplot, UCSC Xena, GEPIA, The Human Protein Atlas, Kaplan–Meier plotter, bc-GenExMiner, cBioPortal, STRING, GeneMANIA, Enrichr, TIMER and shinyDepMap were used for analysis. We found that these genes play their role through the immune system and the high expression of eight FASLG, LTB, TNF, TNFSF8, TNFSF10, TNFSF11, TNFSF12, TNFSF13 genes were positively associated with OS and RFS. Overall, our data showed that these genes can be considered as prognostic biomarkers. Further, our results suggest that this family has anti-tumor activity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
YES
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
